Chemocentryx reported $39.55M in Operating Expenses for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Abbvie ABBV:US $ 10036M 518M
Alexion Pharmaceuticals ALXN:US $ 1000.3M 30.6M
Alnylam Pharmaceuticals ALNY:US $ 369.31M 2.6M
Amgen AMGN:US $ 4.33B 1.37B
AstraZeneca AZN:LN 11.54B 4.45B
Bayer BAYN:GR 9.25B 3.88B
Biogen BIIB:US $ 1984.9M 304.4M
Biomarin Pharmaceutical BMRN:US $ 461.96M 28.06M
Bristol Myers Squibb BMY:US $ 9.63B 360M
Chemocentryx CCXI:US $ 39.55M 1M
Glaxosmithkline GSK:US 7.14B 722M
GlaxoSmithKline GSK:LN 7.14B 722M
Johnson & Johnson JNJ:US $ 19.49B 2.84B
Macrogenics MGNX:US $ 68.65M 2.39M
Merk MRK:US $ 8328M 1460M
Mirati Therapeutics MRTX:US $ 151.29M 12.89M
Novartis NOVN:VX 10.13B 319M
Omeros OMER:US $ 48.26M 4.58M
Pfizer PFE:US $ 16447M 3384M
Sarepta Therapeutics SRPT:US $ 228.35M 103.31M
Takeda 4502:JP 747.39B 46.34B
Teva Pharmaceutical TEVA:IT 3.26B 64M
YTE INCY:US $ 577.58M 12.7M